XmAb 5592 is a humanized, Fc-engineered anti-HM1.24 antibody with enhanced binding to FcgammaRIIIa and FcgammaRIIa receptors, augments HM1.24-specific multiple myeloma (MM) cells lysis in vitro via antibody-dependent cellular cytotoxicity (ADCC) and antibody dependent cellular phagocytosis (ADCP)[1].
Molecular Weight:
(145.8 kDa)
Purity:
99.51
CAS Number:
[1221901-33-2]
Target:
Transmembrane Glycoprotein
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted